Paid Clinical Trials Charleston

Discover 669 paid clinical trials in Charleston, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 669

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaEvaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Charleston SC, Rock Hill SC, Charlotte NC, Jacksonville FLshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting

Sponsor:

Theratechnologies

Location:

Charleston SC, Charlotte NC, Orlando FL, Tampa FLshow 21 more

Code:

NCT05388474

Conditions

HIV Infections

Multi-Antiviral Resistance

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

No ibalizumab or Pre-ibalizumab treatment

On ibalizumab treatment

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Charleston SC, Augusta GA, Boiling Springs SC, Greer SCshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

UC-MSC Cell Therapy Study for SLE PatientsUC-MSC Cell Therapy Study for SLE Patients

Recruiting

PHASE1

Sponsor:

LiveKidney.Bio

Location:

Charleston SC

Code:

NCT06737380

Conditions

SLE

Lupus

Systemic Lupus Erthematosus

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Physical examination

Electrocardiogram

SF-36 questionnaire

Clinical laboratory evaluations - Serology

Clinical laboratory evaluations - Biochemistry

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Charleston SC, Lawrenceville GA, Acworth GA, Orlando FLshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the FutureHuman/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

Recruiting

Sponsor:

International Consortium of Circulatory Assist Clinicians

Location:

Charleston SC, Gainesville FL, Cleveland OH, Chicago ILshow 4 more

Code:

NCT06039176

Conditions

LVAD

Frailty

GI Bleed

Right Heart Failure

Infections

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

HeartMate 3 (R) left ventricular assist device

Study of ALXN2220 Versus Placebo in Adults With ATTR-CMStudy of ALXN2220 Versus Placebo in Adults With ATTR-CM

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Charleston SC, Augusta GA, Jacksonville FL, Greenville SCshow 44 more

Code:

NCT06183931

Conditions

Transthyretin Amyloid Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALXN2220

Placebo

A U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareA U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

Recruiting

Sponsor:

Regeneron Pharmaceuticals

Location:

Summerville SC, Atlanta GA, Ocean City NJ, Camp Hill PAshow 6 more

Code:

NCT06693531

Conditions

Eosinophilic Esophagitis (EoE)

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

dupilumab

Harmony TPV Post-Approval StudyHarmony TPV Post-Approval Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Charleston SC, Charlotte NC, Durham NC, Tampa FLshow 17 more

Code:

NCT05077774

Conditions

Congenital Heart Disease

Tetrology of Fallot

RVOT Anomaly

Pulmonary Regurgitation

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Harmony TPV System

Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and ChemotherapyTabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

Recruiting

PHASE3

Sponsor:

Atara Biotherapeutics

Location:

Charleston SC, Charlotte NC, Chapel Hill NC, Durham NCshow 29 more

Code:

NCT03394365

Conditions

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

Solid Organ Transplant Complications

Lymphoproliferative Disorders

Allogeneic Hematopoietic Cell Transplant

Stem Cell Transplant Complications

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

tabelecleucel